Paid Clinical Trials in Glenview, IL
As of September 2026, 113 paid clinical trials are recruiting in Glenview, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Glenview offers studies at sites including Northwestern Medicine Glenview Outpatient Center for conditions such as Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Crohn's Disease, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Glenview
Trials by drug in Glenview
Filter results
Newly added in Glenview
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
105 clinical trials
Phase 2 Study to Assess the Safety and Efficacy of ANG003
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
Study of DONQ52 in Active Celiac Disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Zenith® Fenestrated+ Clinical Study
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
J-Valve Transfemoral Pivotal Study
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Patient Quality of Recovery After TAVR With Different Sedation Regimens
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Top Research Study Locations in Glenview
Researchers run research studies in Glenview, IL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwestern Medicine Glenview Outpatient Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia | 42 |
| NorthShore University HealthSystem-Glenbrook Hospital | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 32 |
| Endeavor Health | Heart Valve Diseases, Acute Myocardial Infarction, Allergic Reactions | 12 |
| GI Alliance - Glenview | Ulcerative Colitis, Celiac Disease, Crohn's Disease | 6 |
| NorthShore University HealthSystem | Benign Prostatic Hyperplasia (BPH), Cataplexy, EDS | 3 |
| UroPartners | Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms, High-Risk Non-Muscle-Invasive Bladder Cancer | 3 |
| Endeavor Health - Glenbrook Hospital | Cholecystitis, Cholecystitis, Chronic, Chronic Calculous Cholecystitis | 2 |
| Illinois Gastroenterology Group-Glenview powered by GI Alliance | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| NorthShore University Health System | Moderate Aortic Valve Stenosis, Diabetes Mellitus, Type 2, Metabolic Syndrome | 2 |
| NorthShore University Health System - Glenbrook Hospital | Prostate Cancer Screening, Chronic Inflammatory Demyelinating Polyneuropathy | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | 1 |
| CON-10021, Glenview, IL | Heart Failure | 1 |
| Clinical Trial Site | Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | 1 |
| Endeavor Health (Northshore) | Atrial Fibrillation | 1 |
| Endeavor Health - Glenbrook Hospital Ambulatory Care Center | Multiple Myeloma | 1 |
| Endeavor Health Cardiovascular Institute at Glenbrook Hospital | Aortic Aneurysm, Abdominal, Extent IV Thoracoabdominal, Juxtarenal Aortic Aneurysm | 1 |
| Endeavor Health Clinical Trials Center | Urticaria Chronic | 1 |
| GI Alliance - Glenview, IL | Chronic Idiopathic Constipation (CIC) | 1 |
| GI Alliance of Illinois | Crohn Disease (CD), Ulcerative Colitis (UC) | 1 |
| Glenbrook - Endeavor Health | Aortic Valve Disease Mixed, Aortic Valve Regurgitation | 1 |
| Glenbrook Hospital | Pulmonary Embolism | 1 |
| Glenbrook Hospital- Endeavor Health | BPH (Benign Prostatic Hyperplasia), BPH With Symptomatic Lower Urinary Tract Symptoms | 1 |
| Glenview, IL Investigative | Acute Heart Failure, Heart Failure | 1 |
| Lurie Children's | Turner Syndrome | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
Active & Upcoming Studies in Glenview (2026)
Recruiting trials in Glenview grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (59 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (7 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions · Boston Scientific Corporation
Diabetes & metabolic (2 active studies)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- Exercise Strategies in Parkinson's Disease · Shirley Ryan AbilityLab
Common conditions studied in Glenview
- Acute Myeloid Leukemia (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Crohn's Disease (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Ulcerative Colitis (4 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Glenview
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Endeavor Health
Frequently asked questions
How many paid clinical trials are currently recruiting in Glenview?
There are approximately 113 recruiting clinical trials in Glenview, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glenview pay participants?
Most recruiting trials in Glenview compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glenview?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glenview?
The most common conditions under active study in Glenview include Acute Myeloid Leukemia (5), Anatomic Stage II Breast Cancer AJCC v8 (5), Crohn's Disease (4), Stage IV Lung Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glenview?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glenview on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glenview?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glenview?
Recruiting research sites in Glenview include Northwestern Medicine Glenview Outpatient Center, NorthShore University HealthSystem-Glenbrook Hospital, Endeavor Health, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glenview right now?
The largest active categories in Glenview are Cancer & tumors (59), Cardiovascular (7), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.